ESC Premium Access

TWILIGHT-HBR: Ticagrelor Monotherapy in High Bleeding Risk Patients

Congress Presentation

About the speaker

Doctor Davide Cao

Clinical Institute Humanitas Gavazzeni, Bergamo (Italy)
1 presentation
0 follower

2 more presentations in this session

Antiplatelet therapy in high bleeding risk patients with and without oral anticoagulant therapy after coronary stenting

Speaker: Doctor P. Smits (Rotterdam, NL)


SYNTAX II trial: five year follow-up

Speaker: Professor A. Banning (Oxford, GB)


Access the full session

Trial Updates in ACS & PCI

Speakers: Doctor D. Cao, Doctor P. Smits, Professor A. Banning

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb